You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Baxter
Medtronic
Moodys
Harvard Business School

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Propantheline bromide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for propantheline bromide and what is the scope of freedom to operate?

Propantheline bromide is the generic ingredient in two branded drugs marketed by Gd Searle Llc, Shire, Ascot, Heather, Hikma, Impax Labs, Mylan, Par Pharm, Pvt Form, Sandoz, Tablicaps, and Watson Labs, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for propantheline bromide. One supplier is listed for this compound.

Recent Clinical Trials for propantheline bromide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hospital Universitário Professor Edgard SantosPhase 1
Chongqing Medical UniversityPhase 4

See all propantheline bromide clinical trials

Pharmacology for propantheline bromide
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for propantheline bromide

US Patents and Regulatory Information for propantheline bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tablicaps PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 084428-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 080927-002 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial   Start Trial
Par Pharm PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 088377-001 Dec 8, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Shire PRO-BANTHINE propantheline bromide TABLET;ORAL 008732-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Watson Labs PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 083029-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ascot PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 087663-001 Oct 25, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 084541-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Harvard Business School
Colorcon
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.